|
KAPA Sybr Fast qPCR Kits

KAPA SYBR® FAST qPCR Kits contain a novel DNA polymerase
engineered through a process of molecular evolution. The
result is a unique enzyme, specifically evolved for qPCR
using SYBR® Green I dye chemistry.
The KAPA SYBR® DNA Polymerase has been engineered to
perform optimally in stringent qPCR reaction conditions,
exhibiting dramatic improvements in fluorescence, C
ideally suited for:
The first DNA polymerase engineered for real-time PCR.
High performance gene expression analysis
The improved speed, processivity and robustness of KAPA
SYBR® FAST qPCR Kits results in consistently high
amplification efficiencies required for accurate
relative quantification. To demonstrate the high
performance of KAPA SYBR® FAST for gene expression
analysis, the reaction efficiencies obtained for ten
commonly used housekeeping genes in the human breast
cancer cell line, MCF-7, were compared*. The KAPA SYBR®
FAST qPCR Kit achieved consistently high amplification
efficiencies (95 – 104%) across all ten genes, despite
differences in amplicon length.

No bias in amplification efficiency across a wide range
of GC contents (44.2 – 62.5%) or amplicon lengths (86 –
249 bp) was observed with KAPA SYBR® FAST. Amplification
efficiencies achieved for ten housekeeping genes with
the KAPA SYBR® FAST Universal qPCR Kit were plotted
against GC content (top) or amplicon length (bottom).
The reaction efficiency achieved for each of the ten
genes fell within the optimal range of 95 – 105%,
independent of the nature or length of the amplicon.
*For more information see KAPA SYBR® FAST Application
Note: Gene Expression

The housekeeping gene ActB was amplified from a log-fold
serial dilution of MCF-7 cDNA (100 ng to 10 pg/reaction)
using the KAPA SYBR® FAST Universal qPCR Kit (green) or
Competitor I qPCR kit (blue). Linear amplification plots
(top) demonstrate earlier C scores and greater baseline
subtracted fluorescence for the ActB gene with the KAPA
SYBR® FAST Kit. Calculated reaction efficiencies
(bottom) confirmed that the consistently high performance
required for accurate expression quantitation is
achievable with the KAPA SYBR® FAST qPCR Kit (ActB =
100%). Efficiencies obtained with Competitor I were
sub-optimal (107%).
Superior signal and reaction efficiency.

A 290 bp fragment of the human beta-actin gene was
amplified from a set of five 10-fold dilutions of human
genomic DNA (20 ng to 2 pg) using KAPA SYBR® FAST qPCR
Master Mix (green) or fast qPCR competitor kits
(Competitor A, orange or Competitor Q, purple).
Reactions were performed according to each competitors’
suggested protocol on an ABI Prism® 7900 HT real-time
cycler.
High performance with both standard and fast cycling
protocols.

A 150 bp fragment of the human coagulation factor V gene
was amplified from a set of five 10-fold dilutions of
human genomic DNA (20 ng to 2 pg) using KAPA SYBR® FAST,
with a standard cycling protocol (green) or a fast
cycling protocol (blue). Standard cycling conditions: 5
min initial denaturation at 95 °C, followed by 40 cycles
of 15 sec denaturation at 95 °C and 60 sec combined
annealing/extension at 60 °C. Fast cycling conditions: 3
min initial denaturation at 95 °C, followed by 40 cycles
of 1 sec denaturation at 95 °C and 20 sec combined
annealing/extension at 60 °C. The total run time was 1.5
hours for the standard cycling and 40 min for the fast
cycling protocol.
|
Ordering Information |
|
Description |
Code |
Kit contents |
|
KAPA Syber FAST Universal |
KK4600 |
1×1 ml |
|
KAPA Syber FAST Universal |
KK4601 |
1×5 ml |
|
KAPA Syber FAST Universal |
KK4602 |
2×5 ml |
|
KAPA Syber FAST ABI |
KK4603 |
1×1 ml |
|
KAPA Syber FAST ABI |
KK4604 |
1×5 ml |
|
KAPA Syber FAST ABI |
KK4605 |
2×5 ml |
|
KAPA Syber FAST Bio-Rad |
KK4606 |
1×1 ml |
|
KAPA Syber FAST Bio-Rad
iCycler |
KK4607 |
1×5 ml |
|
KAPA Syber FAST Bio-Ras
iCycler |
KK4608 |
2×5 ml |
|
KAPA Syber FAST for Roche LC
480 |
KK4609 |
1×1 ml |
|
KAPA Syber FAST for Roche LC
480 |
KK4610 |
1×5 ml |
|
KAPA Syber FAST for Roche LC
480 |
KK4611 |
2×5 ml |
.............................................................................................................................................................................................
|